Biopharmaceutical aspects of the design of steroidal dosage forms.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000378:metabolism; D000438:Alcohols; D001647:Bile Acids and Salts; D001702:Biopharmaceutics; D055598:Chemical Phenomena; D002621:Chemistry; D004304:Dosage Forms; D004355:Drug Stability; D005782:Gels; D007700:Kinetics; D008566:Membranes; D009821:Oils; D010539:Permeability; D012869:Skin Absorption; D012995:Solubility; D012996:Solutions; D013256:Steroids / Q000008:administration & dosage*; D013501:Surface-Active Agents; D013535:Suspensions; D013607:Tablets
D000305:Adrenal Cortex Hormones; D000438:Alcohols; D001647:Bile Acids and Salts; D004304:Dosage Forms; D005782:Gels; D009821:Oils; D012996:Solutions; D013256:Steroids; D013501:Surface-Active Agents; D013535:Suspensions; D013607:Tablets